From: Impact of oocytes with CLCG on ICSI outcomes and their potential relation to pesticide exposure
 | LCLCG (n = 83) | HCLCG (n = 68) | p-value | |
---|---|---|---|---|
Total number of oocytes | 1178 | 943 | - | |
Oocytes per patient | 14.1 ± 5.7 | 13.6 ± 5.5 | ns | |
MII per patient | 10.4 ± 4.1 | 9.4 ± 4.2 | ns | |
Maturation rate (%) | (868/1178) 74% | (653/943) 69% | ns | |
Embryological outcomes | Fertilization rate (%) | (577/868) 66% | (388/653) 59% | ns |
Cleavage rate (%) | (576/577) 99% | (321/388) 82% | 0.04 (s) | |
Best embryo quality (AÂ +Â B) rate (%) | (358/576) 62% | (200/321) 62% | ns | |
Embryo cryopreservation rate (%) | (150/423) 35% | (78/211) 37% | ns | |
Cryopreserved embryos per patient | 1.8 ± 0.5 | 1.2 ± 0.7 | 0.01 (s) | |
Total number oftransferredembryos | 153 | 110 | - | |
Transferred embryos per patient | 1.9 ± 0.8 | 1.6 ± 1 | ns | |
Total embryo transfer cycles | 79 | 55 | - | |
Clinical outcomes | Clinical pregnancy rate (%) | (28/79) 35% | (15/55) 27% | ns |
Early miscarriage rate (%) | (3/28) 11% | (7/15) 47% | 0.01 (s) | |
Ongoing pregnancy rate (%) | (25/79) 32% | (8/55) 14% | 0.01 (s) | |
Late miscarriage rate (%) | (1/25) 4% | (1/8) 12% | 0.02 (s) | |
Live birth rate (%) | (24/79) 30% | (7/55) 13% | 0.01 (s) |